Genetics Generation Advancement Corp. (TPEX:4160)
Taiwan · Delayed Price · Currency is TWD 49.90
-0.30 (-0.60%)
At close: Feb 11, 2026
TPEX:4160 Market Cap
TPEX:4160 has a market cap or net worth of 1.33 billion as of February 13, 2026. Its market cap has decreased by -26.83% in one year.
Market Cap
1.33B
Enterprise Value
1.02B
Revenue
589.13M
Ranking
n/a
PE Ratio
101.51
Stock Price
49.90
Market Cap Chart
Since July 15, 2011, TPEX:4160's market cap has increased from 957.80M to 1.33B, an increase of 39.05%. That is a compound annual growth rate of 2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.33B | 0.20% |
| Dec 31, 2025 | 1.33B | -27.41% |
| Dec 31, 2024 | 1.83B | 85.27% |
| Dec 29, 2023 | 988.25M | 48.75% |
| Dec 30, 2022 | 664.37M | 10.48% |
| Dec 30, 2021 | 601.33M | 0.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Rossmax International | 1.46B |
| Enimmune | 1.44B |
| DV Biomed | 1.44B |
| Lagis Enterprise | 1.34B |